Síndrome de tracción vitreorretiniana

César Atencia, Hernán Ríos, Francisco J. Rodríguez

Resumen


La Tracción vitreomacular (TVM) hace parte de un grupo de trastornos que
se cree tienen una génesis similar, y teniendo en cuenta las variaciones de la
terminología en la literatura, es fundamental tener claridad sobre los conceptos
básicos, por tal motivo se realiza un artículo de revisión de literatura donde se
describe la historia, defi nición, clasifi cación, asociaciones y nuevos tratamientos
del síndrome de tracción vitreomacular en la actualidad.


Texto completo:

PDF

Referencias


Reese AB, Jones IS, Cooper WC. Vitreomacular traction syndrome

confi rmed histologically. Am J Ophthalmol 1970;69:975-977.

Chen TC, Cense B, Pierce MC, et al. Spectral domain optical

coherence tomography: ultra-high speed, ultra-high resolution

ophthalmic imaging. Arch Ophthalmol 2005;123:1715-1720.

McDonald HR, Johnson RN, Schatz H. Surgical results in the

vitreomacular traction syndrome. Ophthalmology 1994;101:1397-

Shechtman DL, Dunbar MT. Th e expanding spectrum of

vitreomacular traction. Optometry 2009;80:681-687.

Johnson MW. Posterior vitreous detachment: evolution and

complications of its early stages. Am J Ophthalmol 2010;149:371-

Foos RY, Wheeler NC. Vitreoretinal juncture. Synchysis senilis and

posterior vitreous detachment. Ophthalmology 1982;89:1502-

Chuo JY, Lee TY, Hollands H, et al. Risk factors for posterior

vitreous detachment: a case-control study. Am J Ophthalmol.

;142:931-937.

Sebag J. Anomalous posterior vitreous detachment: a unifying

concept in vitreo-retinal disease. Graefes Arch Clin Exp

Ophthalmol. 2004;242:690-698.

Simpson A, Petrarca R, Jackson TL. Vitreomacular adhesion

and

neovascular age-related macular degeneration: a review. Surv Ophthalmol 2012;57:498-509.

Johnson MW. Posterior vitreous detachment: evolution and role

in macular disease. Retina 2012;32:S174-178.

Duker JS, Kaiser PK, Binder S, et al. Th e international vitreomacular

traction study group classifi cation of vitreomacular adhesion,

traction, and macular hole. Ophthalmology 2013;120:2611-2619.

Shao L, Xu L, You QS, et al. Prevalence and associations of

incomplete posterior vitreous detachment in adult Chinese: Th e

Beijing Eye Study. PloS one 2013;8:e58498.

Jackson TL, Nicod E, Simpson A, et al. Symptomatic vitreomacular

adhesion. Retina 2013;33:1503-1511.

Chang LK, Fine HF, Spaide RF, et al. Ultrastructural correlation

of spectral-domain optical coherence tomographic fi ndings

in vitreomacular traction syndrome. Am J Ophthalmol

;146:121-127.

Wu L, Zas M, Berrocal MH, et al. Anatomical and functional

outcomes of symptomatic idiopathic vitreomacular traction. A

Natural History Study From the Pan American Collaborative

Retina Study Group. Retina 2016;36:1913-8.

Stalmans P, Duker JS, Kaiser PK, et al. OCT based interpretation

of the vitreomacular interface and indications for pharmacologic

vitreolysis. Retina 2013;33:2003-2011.

Barak Y, Ihnen MA, Schaal S. Spectral domain optical coherence

tomography in the diagnosis and management of vitreoretinal

interface pathologies. J Ophthalmol 2012;2012:876472.

Goldmann H. Senile changes of the lens and the vitreous: the

Arthur J. Bedell lecture. Am J Ophthalmol 1964;57:1-13.

Johnson MW. Posterior vitreous detachment: evolution and

complications of its early stages. Am J Ophthalmol 2010;149:371-

Sebag J. Anatomy and pathology of the vitreo-retinal interface.

Eye 1992;6:541-552.

Johnson MW. Tractional cystoid macular edema: a subtle variant

of the vitreomacular traction syndrome. Am J Ophthalmol

;140:184-192.

Spaide RF. Vitreomacular traction syndrome. Retina

;32:S187-S190

Sebag J. Vitreoschisis. Graefes Arch Clin Exp Ophthalmol

;246:329-332.

Smiddy WE, Green WR, Michels RG, et al. Ultrastructural

studies of vitreomacular traction syndrome. Am J Ophthalmol

;107:177-185.

Bottós J, Elizalde J, Arevalo JF, et al. Vitreomacular Traction

Syndrome, J Ophthalmic Vis Res 2012;7:148-161.

Ip MS, Baker BJ, Duker JS, et al. Anatomical outcomes of surgery

for idiopathic macular hole as determined by optical coherence

tomography. Arch Ophthalmol 2002;120:29-35.

Ullrich S, Haritoglou C, Gass C, et al. Macular hole size as a

prognostic factor in macular hole surgery. Br J Ophthalmol

;86:390-393.

Gass JD. Reappraisal of biomicroscopic classifi cation of stages of

development of a macular hole. Am J Ophthalmol 1995;119:752-

Stalmans P, Benz MS, Gandorfer A, et al MIVI-TRUST Study

Group. Enzymatic vitreolysis with ocriplasmin for vitreomacular

traction and macular holes. N Engl J Med 2012;367:606-615.

Trese MT, Williams GA, Hartzer MK. A new approach to stage 3

macular holes. Ophthalmology 2000;107:1607-1611.

Chang S. Controversies regarding internal limiting membrane

peeling in idiopathic epiretinal membrane and macular hole.

Retina 2012;32:S200-S204.

Arevalo JF, Sanchez JG, Costa RA, et al. Optical coherence

tomography characteristics of full-thickness traumatic macular

holes. Eye 2008;22:1436–1441.

Singh AJ, Muqit MM, Woon WH. Is axial length a risk factor for

idiopathic macular hole formation?. Int Ophthalmol 2012;32:393-

Shukla D, Naresh KB, Rajendran A, et al. Macular hole secondary

to X-linked retinoschisis. Eye 2006;20:1459-1461.

Shukla D. Evolution and management of macular hole secondary

to type 2 idiopathic macular telangiectasia. Eye 2011;25:532-533.

Sagara N, Kawaji T, Koshiyama Y, et al. Macular hole formation

aft er macular haemorrhage associated with ruptura of retinal

arterial macroaneurysm. Br J Ophthalmol 2009;93:1337-1340.

Van Newkirk MR, Johnson MW, Hughes JR, et al. B-scan

ultrasonographic fi ndings in the stages of idiopathic macular

hole. Trans Am Ophthalmol Soc 2000;98:163-169.

Witkin AJ, Patron ME, Castro LC, et al. Anatomic and visual

outcomes of vitrectomy for vitreomacular traction syndrome.

Ophthalmic Surg Lasers Imaging 2010;41:425-431.

Yamada N, Kishi S. Tomographic features and surgical outcomes

of vitreomacular traction syndrome. Am J Ophthalmol

;139:112-117.

Koizumi H, Spaide RF, Fisher YL, et al. Th ree-dimensional

evaluation of vitreomacular traction and epiretinal membrane

using spectral-domain optical coherence tomography. Am J

Ophthalmol 2008;145:509-517.

Hikichi T, Akiba J, Trempe CL. Eff ect of the vitreous on the

prognosis of full-thickness idiopathic macular hole. Am J

Ophthalmol 1993;116:273-278.

John V, Flynn H, Smiddy W, et al. Clinical course of vitreomacular

adhesion managed by initial observation. Retina 2014;34:442-

Kusaka S, Saito Y, Okada AA, et al. Optical coherence tomography

in spontaneously resolving vitreomacular traction syndrome.

Ophthalmology 2001;215:139-141.

Sulkes DJ, Ip MS, Baumal CR, et al. Spontaneous resolution

of vitreomacular traction documented by optical coherence

tomography. Arch Ophthalmol 2000;118:286-287.

Hikichi T, Yoshida A, Akiba J, et al. Natural outcomes of stage 1, 2,

, and 4 idiopathic macular holes. Br J Ophthalmol 1995;79:517-

Spaide RF, Wong D, Fisher Y, et al. Correlation of vitreous

attachment and foveal deformation in early macular hole states.

Am J Ophthalmol 2002;133:226-229.

Sonmez K, Capone A Jr, Trese MT, et al. Vitreomacular traction

syndrome: impact of anatomical confi guration on anatomical and

visual outcomes. Retina 2008;28:1207–1214.

Th eodossiadis G, Grigoropoulos V, Th eodoropoulou S, et al.

Spontaneous Resolution of Vitreomacular Traction Demonstrated

by Spectral-Domain Optical Coherence Tomography. Am J

Ophthalmol 2014;157:842-851.

Almeida D, Chin E, Rahim K, et al. Factors associated

with spontaneous release of vitreomacular traction. Retina

;35:492-497.

Tzu JH, John VJ, Flynn HW Jr, et al. Clinical course of

vitreomacular traction managed initially by observation.

Ophthalmic Surg Lasers Imaging. Retina 2015;46:571-576.

Th eodossiadis GP, Chatziralli IP, Sergentanis TN, et al. Evolution

of vitreomacular adhesion to acute vitreofoveal separation

with special emphasis on a traction-induced foveal pathology.

A prospective study of spectral-domain optical coherence tomography. Graefes Arch Clin Exp Ophthalmol 2015;253:1425-

Wollensak G, Spoerl E, Grosse G, et al. Biomechanical signifi cance

of the human internal limiting lamina. Retina 2006;26:965-968.

Farah ME, Maia M, Rodrigues EB. Dyes in ocular surgery:

principles for use in chromovitrectomy. Am J Ophthalmol

;148:332-340.

Smiddy WE, Michels RG, Glaser BM, et al. Vitrectomy for

macular traction caused by incomplete vitreous separation. Arch

Ophthalmol 1988;106:624-628.

Melberg NS, Williams DF, Balles MW, et al. Vitrectomy for

vitreomacular traction syndrome with macular detachment.

Retina 1995;15:192-197.

Wu Y, Zhu W, Xu D, et al. Indocyanine green-assisted internal

limiting membrane peeling in macular hole surgery: a metaanalysis.

PloS One 2012;7:e48405

Chung E, Lew Y, Lee H, et al. OCT-guided Hyaloid Release

for Vitreomacular Traction Syndrome, Kor J Ophthalmol

;22:169-173.

Greven M, Garg S, Chiu B, et al. Vitrectomy aft er ocriplasminfor

vitreOmacular adhesion or macular hole (VAVOOM) study. Br J

Ophthalmol 2016;100:1211-5.

Liotta LA, Goldfarb RH, Brundage R, et al. Eff ect of plasminogen

activator (urokinase), plasmin, and thrombin on glycoprotein

and collagenous components of basement membrane. Cancer Res

;41:4629-4636.

Russell SR, Shepherd JD, Hageman GS. Distribution of

glycoconjugates in the human retinal internal limiting membrane.

Invest Ophthalmol Vis Sci 1991;32:1986-1995.

Schneider EW, Johnson MW. Emerging nonsurgical methods

for the treatment of vitreomacular adhesion: a review. Clin.

Ophthalmol 2011;5:1151-1165.

Smet MD, Gandorfer A, Stalmans P, et al. Microplasmin intravitreal

administration in patients with vitreomacular traction scheduled

for vitrectomy: the MIVI I trial. Ophthalmology 2009;116:1349-

Stalmans P, Delaey C, de Smet MD, et al. Intravitreal injection

of microplasmin for treatment of vitreomacular adhesion: results

of a prospective, randomized, sham-controlled phase II trial (the

MIVI-IIT trial). Retina 2010;30:1122-1127.

Haller J, Stalmans P, Benz MS, et al. MIVI-TRUST Study

Group. Effi cacy of Intravitreal Ocriplasmin for Treatment

of Vitreomacular Adhesion: Subgroup Analyses from Two

Randomized Trials, Ophthalmology 2015;122:117-122

Song SJ, Smiddy W. Ocriplasmin for symptomatic vitreomacular

adhesion: an evidence-based review of its potential. Core Evidence

:9:51-9.

Stefanini F, Maia M, Falabella P, et al. Profi le of ocriplasmin and

its potential in the treatment of vitreomacular adhesión, Clin

Ophthalmol 2014:8;847-856.

Haller JA, Stalmans P, Bnez MS, et al. Effi cacy of intravitreal

ocriplasmin for treatment of vitreomacular adhesion: subgroup

analyses from two randomized trials. Ophthalmology

;122:117-122.

Tyler L, Singer M, Bell D. Long-term outcomes in patients with

vitreomacular traction treated with a single intravitreal injection

of ocriplasmin. Retin Cases Brief Rep 2017;11:34-37.

Stalmans P, Duker J, Kaiser P, et al. OCT-based interpretation of

the vitreomacular interface and indications for pharmacologic

vitreolysis, Retina 2013;33:2003-2011.

Tibbetts M, Reichel E, Witkin A, Vision Loss Aft er Intravitreal

Ocriplasmin Correlation of Spectral-Domain Optical Coherence

Tomography and Electroretinography, JAMA Ophthalmol

;132:487-490.

Kim JE. Safety and complications of ocriplasmin: ocriplasmin,

ocriplasmin; oh, how safe art thou? JAMA Ophthalmol

;132:379-380.

Johnson MW, Fahim AT, Rao RC. Acute ocriplasmin retinopathy.

Retina 2015;35:1055-1058.

Chan CK, Wessels IF, Friedrichsen EJ. Treatment of idiopathic

macular holes by induced posterior vitreous detachment.

Ophthalmology 1995;102:757–767

Chan CK, Crosson JN, Mein CE, et al. Pneumatic vitreolysis for

relief of vitreomacular traction. Retina 2017;37:1820-1831.


Enlaces refback

  • No hay ningún enlace refback.


Copyright (c) 2018 César Atencia, Hernán Ríos, Francisco J. Rodríguez

Licencia de Creative Commons
Este obra está bajo una licencia de Creative Commons Reconocimiento-NoComercial 4.0 Internacional.